Provided by Tiger Fintech (Singapore) Pte. Ltd.

Blueprint Medicines

127.85
-0.0500-0.04%
Post-market: 127.76-0.0900-0.07%19:58 EDT
Volume:3.07M
Turnover:392.43M
Market Cap:8.27B
PE:-52.11
High:128.07
Open:128.07
Low:127.77
Close:127.90
Loading ...

Blueprint Medicines: Strong Financial Performance and Strategic Initiatives Justify Buy Rating

TIPRANKS
·
01 May

Earnings Flash (BPMC) Blueprint Medicines Posts Q1 EPS of $0.01, vs. FactSet Est of $-0.49 Loss per Share

MT Newswires Live
·
01 May

Blueprint Medicines Q1 EPS $0.01 Beats $(0.56) Estimate, Sales $149.40M Miss $155.45M Estimate

Benzinga
·
01 May

BRIEF-Blueprint Medicines Q1 Net Income USD 496 Thousand Vs. IBES Estimate USD -35.6 Million

Reuters
·
01 May

Blueprint Medicines Q1 Basic EPS USD 0.01

THOMSON REUTERS
·
01 May

Blueprint Medicines Reports First Quarter 2025 Results and Raises Ayvakit®/Ayvakyt® (Avapritinib) Full Year Revenue Guidance

THOMSON REUTERS
·
01 May

Blueprint Medicines Reports First Quarter 2025 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance

PR Newswire
·
01 May

Blueprint Medicines Corp expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
29 Apr

Blueprint Medicines Is Maintained at Buy by Needham

Dow Jones
·
29 Apr

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
24 Apr

Blueprint Medicines Corporation (BPMC): Among Takeover Rumors Hedge Funds Are Buying

Insider Monkey
·
24 Apr

3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
22 Apr

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC)

TIPRANKS
·
17 Apr

Blueprint Medicines Price Target Maintained With a $128.00/Share by Wedbush

Dow Jones
·
16 Apr

Adma Biologics (ADMA) Moves 7.8% Higher: Will This Strength Last?

Zacks
·
15 Apr

Blueprint Medicines: Strong Growth Potential Driven by Ayvakit and Promising Pipeline

TIPRANKS
·
08 Apr

Blueprint Medicines Corp : Morgan Stanley Assumes Coverage With Equal Weight Rating; Price Target $100 VS $120

THOMSON REUTERS
·
20 Mar

Balanced Outlook on Blueprint Medicines: Growth Prospects and Market Dynamics

TIPRANKS
·
20 Mar

Blueprint Medicines assumed with an Equal Weight at Morgan Stanley

TIPRANKS
·
20 Mar

Reddit initiated, Netflix upgraded: Wall Street’s top analyst calls

TipRanks
·
18 Mar